Spire Healthcare Group has appointed Debbie White as interim chair of the company, one of the largest independent hospital operators in the United Kingdom. The appointment took effect on 5 September 2026, the date on which the London listed group announced a recommended cash acquisition by a private consortium.
White holds the role on an interim footing. The announcement states that she is expected to step down once the acquisition completes, at which point the acquiring vehicle intends to appoint a new chair alongside a new chief executive to lead the business in private ownership.
Her move into the chair follows the succession plan Spire Healthcare set out on 14 July 2026. Under that plan Sir Ian Cheshire stepped down as non executive chair and White, who had been serving as chair designate since July, moved directly into the role, giving the board an orderly handover at the moment the offer was agreed. In the same announcement, Sir David Sloman, a non executive director, was appointed interim chief executive with immediate effect, so that both transitions were completed on a single orderly timetable.
White is not new to the Spire Healthcare board. She joined as an independent non executive director in February 2023 and became senior independent director in May 2023. She has chaired the audit and risk committee on an interim basis since September 2024, giving her close sight of the group's financial reporting and risk framework through the strategic review that preceded the offer.
Her executive career was built in outsourcing and services. Her last full time executive role was chief executive officer of Interserve Group. Before that she spent an extended period at Sodexo, where she served as global chief executive officer of Sodexo Healthcare and Sodexo Government, as chief financial officer of the North American and the UK and Ireland businesses, and as chief executive officer of the UK and Ireland operation. She is a chartered accountant and a chartered tax practitioner. Her other current commitments include the chair of The Co-operative Group.
The chair role at Spire Healthcare carries unusual weight at present. The group runs 38 hospitals and a wider network of clinics across England, Wales and Scotland, works with more than 8,800 consultants, and delivered care to over 1.36 million inpatients, outpatients, day case patients and workplace health clients in 2025. It is the leading private provider by volume of knee and hip operations in the United Kingdom and a substantial supplier of publicly funded elective work.
The board White now leads has recommended a cash offer of 250 pence per share from a consortium led by Toscafund Asset Management, valuing the company's share capital at about 1.03 billion pounds. The offer is to be implemented by a court sanctioned scheme of arrangement, with an unlisted rollover equity alternative available to shareholders who prefer to stay invested. Shareholders representing 53.4 per cent of the stock have already committed to back the deal.
The commercial job in front of White is therefore stewardship rather than fresh strategy. She has to hold the board together through the scheme timetable, keep clinical quality and operational stability in focus while ownership changes hands, and hand over a functioning governance structure to the incoming chair. Her comment on the transaction pointed to progress on care quality, revenue diversification and efficiency, but also to volatility in the independent healthcare sector and to material cost pressures including higher national insurance contributions and a higher national minimum wage.
For the wider market, her appointment marks the point at which the United Kingdom's largest listed independent hospital group begins its exit from public ownership under a chair whose brief is continuity.
